Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trial

DSpace Repository

Show simple item record

dc.contributor.author Norz, Valentina
dc.contributor.author Lawaczeck, Laura
dc.contributor.author Bedke, Jens
dc.contributor.author Rausch, Steffen
dc.contributor.author Stenzl, Arnulf
dc.date.accessioned 2020-12-28T08:18:05Z
dc.date.available 2020-12-28T08:18:05Z
dc.date.issued 2020
dc.identifier.issn 1744-8301
dc.identifier.uri http://hdl.handle.net/10900/110932
dc.language.iso en de_DE
dc.publisher Future Medicine Ltd de_DE
dc.relation.uri http://dx.doi.org/10.2217/fon-2019-0509 de_DE
dc.subject.ddc 610 de_DE
dc.title Enzalutamide plus androgen-deprivation therapy in hormone-sensitive prostate cancer: new perspectives from a current Phase III clinical trial de_DE
dc.type Artikel de_DE
utue.quellen.id 20200929220116_00698
utue.publikation.seiten 1511-1523 de_DE
utue.personen.roh Norz, Valentina
utue.personen.roh Lawaczeck, Laura
utue.personen.roh Bedke, Jens
utue.personen.roh Rausch, Steffen
utue.personen.roh Stenzl, Arnulf
dcterms.isPartOf.ZSTitelID Future Oncology de_DE
dcterms.isPartOf.ZS-Issue 21 de_DE
dcterms.isPartOf.ZS-Volume 16 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record